102.69 USD
+1.44
1.42%
At close Dec 20, 4:00 PM EST
After hours
102.69
+0.00
0.00%
1 day
1.42%
5 days
-1.58%
1 month
-6.85%
3 months
-4.85%
6 months
14.41%
Year to date
23.31%
1 year
27.22%
5 years
93.24%
10 years
233.08%
 

About: Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Employees: 12,785

0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

115% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 87

78% more call options, than puts

Call options by funds: $543M | Put options by funds: $306M

67% more funds holding in top 10

Funds holding in top 10: 18 [Q2] → 30 (+12) [Q3]

18% more capital invested

Capital invested by funds: $35.3B [Q2] → $41.5B (+$6.25B) [Q3]

7% more funds holding

Funds holding: 1,420 [Q2] → 1,520 (+100) [Q3]

3.2% less ownership

Funds ownership: 69.64% [Q2] → 66.44% (-3.2%) [Q3]

20% less repeat investments, than reductions

Existing positions increased: 464 | Existing positions reduced: 581

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$90
12%
downside
Avg. target
$107
5%
upside
High target
$124
21%
upside

7 analyst ratings

positive
29%
neutral
57%
negative
14%
Evercore ISI Group
Thomas Gallagher
44% 1-year accuracy
7 / 16 met price target
1%downside
$102
Underperform
Maintained
4 Dec 2024
Wells Fargo
Elyse Greenspan
57% 1-year accuracy
52 / 91 met price target
4%upside
$107
Equal-Weight
Maintained
5 Nov 2024
Truist Securities
Mark Hughes
70% 1-year accuracy
45 / 64 met price target
2%upside
$105
Hold
Maintained
1 Nov 2024
B of A Securities
Joshua Shanker
44% 1-year accuracy
24 / 54 met price target
21%upside
$124
Buy
Maintained
10 Oct 2024
TD Cowen
Andrew Kligerman
62% 1-year accuracy
8 / 13 met price target
1%downside
$102
Hold
Initiated
9 Oct 2024

Financial journalist opinion

Based on 7 articles about AFL published over the past 30 days

Positive
Zacks Investment Research
2 weeks ago
Aflac Approves a 16% Dividend Hike, Boosts Shareholder Value
AFL raises its quarterly dividend to 58 cents per share, indicating a strong financial position and prudent capital deployment initiatives.
Aflac Approves a 16% Dividend Hike, Boosts Shareholder Value
Neutral
PRNewsWire
2 weeks ago
Aflac Incorporated Announces 16.0% Increase in the First Quarter 2025 Dividend
COLUMBUS, Ga. , Dec. 2, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has declared the first quarter dividend of $0.58 per share, payable on March 3, 2025, to shareholders of record at the close of business on February 19, 2025.
Aflac Incorporated Announces 16.0% Increase in the First Quarter 2025 Dividend
Positive
Zacks Investment Research
3 weeks ago
Here's Why Investors Should Add Aflac Stock to Their Portfolio Now
Sales growth in the U.S. and Japan segments, coupled with operational improvements, should aid AFL well for growth.
Here's Why Investors Should Add Aflac Stock to Their Portfolio Now
Positive
Zacks Investment Research
3 weeks ago
Why Is Aflac (AFL) Up 8.9% Since Last Earnings Report?
Aflac (AFL) reported earnings 30 days ago. What's next for the stock?
Why Is Aflac (AFL) Up 8.9% Since Last Earnings Report?
Neutral
PRNewsWire
4 weeks ago
My Special Aflac Duck® lands in the Sacramento Valley
Comforting robotic companions donated to pediatric cancer patients courtesy of Aflac ROSEVILLE Calif. , Nov. 21, 2024 /PRNewswire/ -- Children in Northern California now have a cuddly companion to bring them comfort through their cancer treatment journey.
My Special Aflac Duck® lands in the Sacramento Valley
Neutral
PRNewsWire
4 weeks ago
Aflac Incorporated to Webcast 2024 Financial Analysts Briefing
COLUMBUS, Ga. , Nov. 21, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will webcast its annual Financial Analysts Briefing on December 3, 2024 at starting 8:00 a.m.
Aflac Incorporated to Webcast 2024 Financial Analysts Briefing
Positive
Zacks Investment Research
4 weeks ago
Aflac (AFL) Upgraded to Buy: Here's Why
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Aflac (AFL) Upgraded to Buy: Here's Why
Neutral
PRNewsWire
1 month ago
American workforce burnout reaches tipping point
14th annual Aflac WorkForces Report uncovers very high levels of burnout are  nearly twice as likely among U.S. Hispanic employees than non-Hispanics COLUMBUS, Ga. , Nov. 12, 2024 /PRNewswire/ -- American employers and employees are facing a conundrum: heightened levels of workplace stress and burnout.
American workforce burnout reaches tipping point
Neutral
PRNewsWire
1 month ago
Aflac hires JR Shamley as senior vice president, National Account Business Development and Growth Solutions
30-year group insurance industry veteran will leverage his carrier and benefits consulting experience to further deepen Aflac's distribution model and drive profitable growth COLUMBUS, Ga. , Nov. 11, 2024 /PRNewswire/ -- Aflac, the leading provider of supplemental health insurance in the U.S.1, today announced the hiring of JR Shamley for the newly created position of senior vice president, National Account Business Development and Growth Solutions.
Aflac hires JR Shamley as senior vice president, National Account Business Development and Growth Solutions
Positive
Zacks Investment Research
1 month ago
Down -6.55% in 4 Weeks, Here's Why Aflac (AFL) Looks Ripe for a Turnaround
Aflac (AFL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down -6.55% in 4 Weeks, Here's Why Aflac (AFL) Looks Ripe for a Turnaround
Charts implemented using Lightweight Charts™